Clinical Trial Detail

NCT ID NCT03007407
Title Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors NSABP Foundation Inc
Indications

colorectal adenocarcinoma

Therapies

Tremelimumab

Durvalumab

Age Groups: adult senior

No variant requirements are available.